iBio
IBIO
#10074
Rank
C$37.27 M
Marketcap
C$1.66
Share price
-6.25%
Change (1 day)
-54.35%
Change (1 year)

iBio (IBIO) - Total assets

Total assets on the balance sheet as of June 2025 : C$32.03 Million

According to iBio's latest financial reports the company's total assets are C$32.03 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

iBio - Total assets on balance sheet (from 2008 to 2025)

Total assets by year

Year Total assets Change
2024-06-30C$39.28 M-27.96%
2023-06-30C$54.53 M-57.38%
2022-06-30C$0.12 B-29.74%
2021-06-30C$0.18 B42.45%
2020-06-30C$0.12 B219.33%
2019-06-30C$40.03 M-29.33%
2018-06-30C$56.65 M21.11%
2017-06-30C$46.77 M-30.04%
2016-06-30C$66.86 M328.92%
2015-06-30C$15.58 M124.95%
2014-06-30C$6.92 M-29.53%
2013-06-30C$9.83 M-1.09%
2012-06-30C$9.94 M40.63%
2011-06-30C$7.07 M35.46%
2010-06-30C$5.21 M-7.86%
2009-06-30C$5.66 M56.68%
2008-06-30C$3.61 M-9.48%
2007-06-30C$3.99 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Genocea Biosciences
GNCA
C$53.58 M 67.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$2.01 B 6,201.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$266.37 B 831,541.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
C$0.41 B 1,199.75%๐Ÿ‡บ๐Ÿ‡ธ USA